Q32 Bio Inc. — Investor Relations & Filings
Filings indexed
506
across all filing types
Latest filing
2026-05-05
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
QTTB
Q32 Bio Inc. is a clinical-stage biotechnology company developing therapies to restore healthy immune balance in patients with autoimmune and inflammatory diseases. The company's therapeutic approach targets powerful regulators of both the innate and adaptive immune systems. Its most advanced product candidate, bempikibart (ADX-914), is a fully human anti-interleukin-7 receptor alpha (IL-7Rα) antagonist monoclonal antibody. Bempikibart is designed to re-regulate adaptive immune function by blocking signaling from both interleukin-7 (IL-7) and thymic stromal lymphopoietin (TSLP). The candidate is currently being evaluated in a Phase 2 program for the treatment of alopecia areata.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Q32 Bio Inc. (0001661998) (Filer) | 2026-05-05 | English | |
| 8-K - Q32 Bio Inc. (0001661998) (Filer) | 2026-05-05 | English | |
| ARS - Q32 Bio Inc. (0001661998) (Filer) | 2026-04-30 | English | |
| DEF 14A - Q32 Bio Inc. (0001661998) (Filer) | 2026-04-30 | English | |
| 424B5 - Q32 Bio Inc. (0001661998) (Filer) | 2026-04-24 | English | |
| 4 - Q32 Bio Inc. (0001661998) (Issuer) | 2026-03-21 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41350292 | 10-Q - Q32 Bio Inc. (0001661998) (Filer) | 2026-05-05 | English | ||
| 41346460 | 8-K - Q32 Bio Inc. (0001661998) (Filer) | 2026-05-05 | English | ||
| 39072013 | ARS - Q32 Bio Inc. (0001661998) (Filer) | 2026-04-30 | English | ||
| 39069697 | DEF 14A - Q32 Bio Inc. (0001661998) (Filer) | 2026-04-30 | English | ||
| 36267508 | 424B5 - Q32 Bio Inc. (0001661998) (Filer) | 2026-04-24 | English | ||
| 33003133 | 4 - Q32 Bio Inc. (0001661998) (Issuer) | 2026-03-21 | English | ||
| 33003135 | 4 - Q32 Bio Inc. (0001661998) (Issuer) | 2026-03-21 | English | ||
| 33003131 | 4 - Q32 Bio Inc. (0001661998) (Issuer) | 2026-03-21 | English | ||
| 32896138 | 4 - Q32 BIO INC. (0001661998) (Filer) | 2026-02-27 | English | ||
| 32896139 | 4 - Q32 BIO INC. (0001661998) (Filer) | 2026-02-27 | English | ||
| 32896140 | 4 - Q32 BIO INC. (0001661998) (Filer) | 2026-02-27 | English | ||
| 31187430 | 8-K Filing | 2026-02-17 | English | ||
| 31187392 | 424B5 Filing | 2026-02-17 | English | ||
| 31187419 | 4 Filing | 2026-01-30 | English | ||
| 31187399 | 4 Filing | 2026-01-30 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aptose Biosciences Inc.
Clinical-stage company developing targeted precision medici…
|
APS | CA | Professional, scientific and te… |
|
APURES CO., LTD.
Biotech firm providing MICROPIG models, bio-resources, and …
|
149300 | KR | Professional, scientific and te… |
|
Aran Research & Development (1982) Ltd.
A product design and development firm providing services fr…
|
ARAN | IL | Professional, scientific and te… |
|
Arch Biopartners Inc.
Developing novel drugs for acute kidney injury (AKI) and ch…
|
ARCH | CA | Professional, scientific and te… |
|
ARCHER MATERIALS LIMITED
Develops semiconductor devices for quantum computing and me…
|
AXE | AU | Professional, scientific and te… |
|
ARGENICA THERAPEUTICS LIMITED
Clinical-stage developer of neuroprotective drugs for acute…
|
AGN | AU | Professional, scientific and te… |
|
ARIUS Research Inc.
Discovery and development of targeted antibody therapeutics…
|
ARI | CA | Professional, scientific and te… |
|
AROVELLA THERAPEUTICS LIMITED
Develops off-the-shelf iNKT cell therapies for blood cancer…
|
ALA | AU | Professional, scientific and te… |
|
Artiva Biotherapeutics, Inc.
Develops allogeneic, off-the-shelf NK cell therapies for ca…
|
ARTV | US | Professional, scientific and te… |
|
ARVINAS, INC.
Clinical-stage biopharma developing therapeutics based on t…
|
ARVN | US | Professional, scientific and te… |
Q32 Bio Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34891/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34891 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34891 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34891 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34891}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Q32 Bio Inc. (id: 34891)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.